ISH(In Situ Hybridization) ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ - Á¦°ø Á¦Ç°º°, ±â¼úº°, ¿ëµµº°, ÃÖÁ¾ »ç¿ëÀÚº°, Áö¿ªº°, ½ÃÀå ¿¹Ãø(2025-2034³â)
In Situ Hybridization Market Size, Share, Trends, & Industry Analysis Report By Offering (Consumables, Instruments, and Services & Software), By Technology, By Application, By End User, and By Region - Market Forecast, 2025-2034
»óǰÄÚµå : 1786896
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 129 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,981,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,389,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,796,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃÖ±Ù Á¶»ç¿¡ µû¸£¸é ISH(In Situ Hybridization) ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 30¾ï 1,557¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù. ÀÌ ¼³¹®Á¶»ç º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇÐÀ» ÀÚ¼¼È÷ ÆÄ¾ÇÇϰí ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

ISH(In Situ Hybridization)´Â Á¶Á÷ ±¸Á¶ ³»¿¡¼­ À¯ÀüÀÚ ¹ßÇö ¹× ¿°»öüÀÇ Æ¯Â¡À» Á÷Á¢ ºÐ¼®ÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀÓ»ó ¹× ¿¬±¸ ȯ°æ Àü¹Ý¿¡ °ÉÃÄ Áö¼ÓÀûÀ¸·Î Áö¿øµË´Ï´Ù. ¾Ï ÀÓ»ó½ÃÇè, º´¸®ÇÐ, À¯ÀüÇÐ µîÀÇ ºÐ¾ß¿¡¼­ ÀÌ¿ëÀÌ È®´ëµÇ°í ÀÖ´Â °ÍÀº Áø´ÜÀ̳ª Ä¡·á °èȹ¿¡ À¯Àü¹°ÁúÀÇ Á¤È®ÇÑ °ø°£ ¸ÅÇÎÀÌ ºÒ°¡°áÇÑ ¾Ï, Èñ¼ÒÁúȯÀÇ À¯ÀüÀÚ °Ë»ç, °¨¿°Áõ µîÀÇ À¯º´·ü Áõ°¡°¡ ¹è°æ¿¡ ÀÖ½À´Ï´Ù.

ÇÁ·Îºê ¶óº§¸µ, µðÁöÅÐ À̹Ì¡, ½Ã½ºÅÛ ÀÚµ¿È­ÀÇ ÃÖ±Ù ¹ßÀüÀº ISH ¿öÅ©Ç÷οìÀÇ °¨µµ¿Í È®À强À» ÇöÀúÇÏ°Ô Çâ»ó½ÃÄ×½À´Ï´Ù. FISH¿Í °°Àº Çü±¤ ±â¹Ý ±â¼úÀÇ ÃâÇö°ú À̹ÌÁö ºÐ¼®À» À§ÇÑ ÀΰøÁö´ÉÀÇ ÅëÇÕÀº °Ë»ç½ÇÀÌ Áø´Ü Á¤È®µµ¸¦ ³ôÀ̰í, ¼Ò¿ä ½Ã°£À» ´ÜÃàÇϸç, ³ôÀº 󸮷® »ùÇà Æò°¡¸¦ Áö¿øÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù.

ISH(In Situ Hybridization) ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

¿ëµµº°·Î´Â ÀÓ»ó Áø´Ü ºÐ¾ß°¡ 2024³â ½ÃÀåÀ» ¸®µåÇß½À´Ï´Ù. ¾Ï°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·üÀÌ »ó½ÂÇϰí Á¤È®ÇÑ Á¶±â ¹ß°ß¹ý¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁö°í ÀÖ´Â °ÍÀÌ ¹è°æ¿¡ ÀÖ½À´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î º¹ÀâÇÑ ºÐÀÚ »ý¹°ÇÐ ¼­ºñ½ºÀÇ ¾Æ¿ô¼Ò½Ì Áõ°¡·Î ÀÎÇØ °è¾à ¿¬±¸ ±â°ü(CRO)ÀÌ °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÏ¹Ì´Â ÷´Ü ÇコÄɾî ÀÎÇÁ¶ó¿Í È®¸³µÈ Áø´Ü ´É·Â¿¡ ÈûÀÔ¾î 2024³â ÃÖ´ë ÆÇ¸Å Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀåÀº »ý¸í °úÇÐ ¿¬±¸ ¹× ºÐÀÚÁø´Ü ÀÎÇÁ¶ó °³¹ß ÅõÀÚ Áõ°¡·Î ÀÎÇØ °¡Àå ºü¸¥ ¼Óµµ·Î È®´ëµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÁÖ¿ä ½ÃÀå ¾÷ü´Â Abbott Laboratories, Inc., Advanced Cell Diagnostics, Inc., Agilent Technologies, Inc., Bio SB, Inc., Bio-Techne Corporation, BioCare Medical, LLC, BioGenex Laboratories, Inc., Bio-Rad Laboratories, Inc., BioView Ltd., F. Hoffmann-La Roche Ltd µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°èÀÇ ISH(In Situ Hybridization) ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ISH(In Situ Hybridization) ½ÃÀå : Á¦°øº°

Á¦6Àå ¼¼°èÀÇ ISH(In Situ Hybridization) ½ÃÀå : ±â¼úº°

Á¦7Àå ¼¼°èÀÇ ISH(In Situ Hybridization) ½ÃÀå : ¿ëµµº°

Á¦8Àå ¼¼°èÀÇ ISH(In Situ Hybridization) ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

Á¦9Àå ¼¼°èÀÇ ISH(In Situ Hybridization) ½ÃÀå : Áö¿ªº°

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

AJY
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The in situ hybridization market size is expected to reach USD 3,015.57 Million by 2034, according to a new study by Polaris Market Research. The report "In Situ Hybridization Market Size, Share, Trends, & Industry Analysis Report By Offering (Consumables, Instruments, and Services & Software), By Technology, By Application, By End User, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

In situ hybridization (ISH) continues to gain traction across clinical and research environments due to its capability to analyze gene expression and chromosomal features directly within tissue architecture. Its expanding use in fields such as oncology clinical trials, pathology, and genetics is supported by the growing prevalence of cancer, rare disease genetic testing, and infectious conditions where accurate spatial mapping of genetic material is essential for diagnosis and treatment planning.

Recent advancements in probe labeling, digital imaging, and system automation have significantly improved the sensitivity and scalability of ISH workflows. The emergence of fluorescence-based techniques such as FISH and the integration of artificial intelligence for image analysis are helping laboratories enhance diagnostic precision, reduce turnaround times, and support high-throughput sample evaluation.

In Situ Hybridization Market Report Highlights

In terms of application, the clinical diagnostics segment led the market in 2024, driven by rising prevalence of chronic diseases like cancer and growing demand for accurate early detection methods.

Based on end user, the contract research organizations (CROs) are expected to grow the fastest, benefiting from increased outsourcing of complex molecular biology services.

North America held the largest revenue share in 2024, supported by its advanced healthcare infrastructure and established diagnostic capabilities.

The Asia Pacific market is anticipated to expand at the fastest rate, fueled by growing investments in life sciences research and molecular diagnostics infrastructure development.

A few global key market players include Abbott Laboratories, Inc., Advanced Cell Diagnostics, Inc., Agilent Technologies, Inc., Bio SB, Inc., Bio-Techne Corporation, BioCare Medical, LLC, BioGenex Laboratories, Inc., Bio-Rad Laboratories, Inc., BioView Ltd., F. Hoffmann-La Roche Ltd.

Polaris Market Research has segmented the market report on the basis of offering, technology, application, end user, and region:

By Offering Outlook (Revenue, USD Million, 2020-2034)

Consumables

Instruments

Services & Software

By Technology Outlook (Revenue, USD Million, 2020-2034)

Fluorescent In Situ Hybridization (Fish)

Chromogenic In Situ Hybridization (Cish)

By Application Outlook (Revenue, USD Million, 2020-2034)

Clinical Diagnostics

Research Applications

Drug Discovery & Development

By End User Outlook (Revenue, USD Million, 2020-2034)

Pharmaceutical & Biotechnology Companies

Hospitals & Diagnostic Laboratories

Academic & Research Institutes

Contract Research Organizations

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global In Situ Hybridization Market Insights

5. Global In Situ Hybridization Market, by Offering

6. Global In Situ Hybridization Market, by Technology

7. Global In Situ Hybridization Market, by Application

8. Global In Situ Hybridization Market, by End User

9. Global In Situ Hybridization Market, by Geography

10. Competitive Landscape

11. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â